These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8867021)

  • 21. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia.
    Treves TA; Bornstein NM; Chapman J; Klimovitzki S; Verchovsky R; Asherov A; Veshchev IO; Korczyn AD
    Alzheimer Dis Assoc Disord; 1996; 10(4):189-91. PubMed ID: 8939277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
    Minthon L; Hesse C; Sjögren M; Englund E; Gustafson L; Blennow K
    Neurosci Lett; 1997 Apr; 226(1):65-7. PubMed ID: 9153643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.
    Gearing M; Schneider JA; Rebeck GW; Hyman BT; Mirra SS
    Neurology; 1995 Nov; 45(11):1985-90. PubMed ID: 7501146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.
    Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM
    Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
    Kosunen O; Talasniemi S; Lehtovirta M; Heinonen O; Helisalmi S; Mannermaa A; Paljärvi L; Ryynänen M; Riekkinen PJ; Soininen H
    Stroke; 1995 May; 26(5):743-8. PubMed ID: 7740560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E genotypes and longevity across dementia disorders.
    Skillbäck T; Lautner R; Mattsson N; Schott JM; Skoog I; Nägga K; Kilander L; Wimo A; Winblad B; Eriksdotter M; Blennow K; Zetterberg H
    Alzheimers Dement; 2018 Jul; 14(7):895-901. PubMed ID: 29548722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.
    Raha-Chowdhury R; Henderson JW; Raha AA; Vuono R; Bickerton A; Jones E; Fincham R; Allinson K; Holland A; Zaman SH
    J Alzheimers Dis; 2019; 69(1):91-109. PubMed ID: 30909239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.
    Rodriguez Martin T; Calella AM; Silva S; Munna E; Modena P; Chiesa R; Terrevazzi S; Ruggieri RM; Palermo R; Piccoli F; Confalonieri R; Tiraboschi P; Fragiacomo C; Quadri P; Lucca U; Forloni G
    Dement Geriatr Cogn Disord; 2000; 11(5):239-44. PubMed ID: 10940674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
    Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
    Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease.
    Hardy J; Crook R; Prihar G; Roberts G; Raghavan R; Perry R
    Neurosci Lett; 1994 Nov; 182(1):1-2. PubMed ID: 7891871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
    Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
    Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.
    Arai H; Higuchi S; Sasaki H
    Gerontology; 1997; 43 Suppl 1():2-10. PubMed ID: 9187933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease.
    Lannfelt L; Lilius L; Nastase M; Viitanen M; Fratiglioni L; Eggertsen G; Berglund L; Angelin B; Linder J; Winblad B
    Neurosci Lett; 1994 Mar; 169(1-2):175-8. PubMed ID: 8047277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.